Cancer Research Targets  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sheu, B.-C.
Right arrow Articles by Hsu, S.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sheu, B.-C.
Right arrow Articles by Hsu, S.-M.
[Cancer Research 65, 2921-2929, April 1, 2005]
© 2005 American Association for Cancer Research


Immunology

Up-regulation of Inhibitory Natural Killer Receptors CD94/NKG2A with Suppressed Intracellular Perforin Expression of Tumor-Infiltrating CD8+ T Lymphocytes in Human Cervical Carcinoma

Bor-Ching Sheu1, Shin-Heng Chiou1,3, Ho-Hsiung Lin1, Song-Nan Chow1, Su-Cheng Huang1, Hong-Nerng Ho1,3 and Su-Ming Hsu2

Departments of 1 Obstetrics and Gynecology and 2 Pathology, National Taiwan University Hospital and 3 Graduate Institute of Immunology, National Taiwan University College of Medicine, Taipei, Taiwan

Requests for reprints: Hong-Nerng Ho or Su-Cheng Huang, Department of Obstetrics and Gynecology, National Taiwan University Hospital, No.7 Chung-Shan South Road, Taipei, 100, Taiwan. Phone: 886-2-2364-8233; Fax: 886-2-2709-2570; E-mail: bcsheu{at}ha.mc.ntu.edu.tw.

Inhibitory signals that govern the cytolytic functions of CD8+ T lymphocytes have been linked to the expression of natural killer cell receptors (NKRs) on CTLs. There is limited knowledge about the induction of inhibitory NKR (iNKR) expression in vivo. Up-regulation of iNKRs has been linked to the modulation of the virus- and/or tumor-specific immune responses in animal models. In the present study, we directly examined the expression of various NKRs on tumor-infiltrating lymphocytes (TILs) derived from human cervical cancer. We found that in human cervical cancer, the percentage expression of immunoglobulin-like NKR+CD8+ T lymphocytes were similar in gated CD8+-autologous TILs and peripheral blood mononuclear cells. On the contrary, cervical cancer–infiltrating CD8+ T lymphocytes expressed up-regulated C-type lectin NKRs CD94/NKG2A compared with either peripheral blood CD8+ T cells or normal cervix-infiltrating CD8+ T lymphocytes. Dual NKR coexpression analyses showed that CD94 and NKG2A were mainly expressed on CD56CD161CD8+ TILs within the cancer milieu. Immunohistochemical study showed that cervical cancer cells expressed abundant interleukin 15 (IL-15) and transforming growth factor-ß (TGF-ß). In kinetic coculture assay, cervical cancer cells can promote the expression of CD94/NKG2A on CD8+ T lymphocytes. The cancer-derived effects can be reversed by addition of rIL-15R{alpha}/Fc and anti–TGF-ß antibody. Functional analyses illustrated that intracellular perforin expression of CD8+ T cells was minimal upon up-regulation of CD94/NKG2A. Kinetic cytotoxicity assays showed that up-regulated expressions of CD94/NKG2A restrain CD8+ T lymphocyte cytotoxicity. Our study strongly indicated that cervical cancer cells could promote the expression of iNKRs via an IL-15– and possibly TGF-ß–mediated mechanism and abrogate the antitumor cytotoxicity of TILs.

Key Words: human • T lymphocyte • NK receptor • tumor immunology • perforin




This article has been cited by other articles:


Home page
J. Virol.Home page
D.-W. Liu, Y.-C. Yang, H.-F. Lin, M.-F. Lin, Y.-W. Cheng, C.-C. Chu, Y.-P. Tsao, and S.-L. Chen
Cytotoxic T-Lymphocyte Responses to Human Papillomavirus Type 16 E5 and E7 Proteins and HLA-A*0201-Restricted T-Cell Peptides in Cervical Cancer Patients
J. Virol., March 15, 2007; 81(6): 2869 - 2879.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. G. Iliopoulou, M. V. Karamouzis, I. Missitzis, A. Ardavanis, N. N. Sotiriadou, C. N. Baxevanis, G. Rigatos, M. Papamichail, and S. A. Perez
Increased Frequency of CD4+ Cells Expressing CD161 in Cancer Patients
Clin. Cancer Res., December 1, 2006; 12(23): 6901 - 6909.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. J. Lucas, S.-J. Kim, C. L. Mackall, W. G. Telford, Y.-W. Chu, F. T. Hakim, and R. E. Gress
Dysregulation of IL-15-mediated T-cell homeostasis in TGF-beta dominant-negative receptor transgenic mice
Blood, October 15, 2006; 108(8): 2789 - 2795.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.